Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health - Teladoc Health ( NYSE:TDOC )
MELBOURNE, Australia, Aug. 14, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health TDOC, the global leader in virtual care, today announced it has acquired Telecare, an innovative, Australian tech-enabled provider of specialist and allied health care via virtual delivery.
Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health
Telecare operates Australia's leading virtual care clinic and provides software solutions to the healthcare sector.
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit?
HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.
2 Stocks Down More Than 90% That Still Aren't Worth Buying
There's still considerable downside risk for these beaten-down companies.
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care
HIMS leverages its consumer-first telehealth model, AI-driven personalization and global expansion plans to outpace industry growth.
Stock Market Today: Hims & Hers Tumbles 12% on Revenue Miss Despite 73% Growth
Hims & Hers stock fell sharply Tuesday after the company missed Q2 revenue estimates, despite strong growth and reaffirmed guidance.
Teladoc ( TDOC ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.July 29, 2025, 8:30 p.m. ETChief Executive Officer - Chuck DivitaContinue reading ...
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
TDOC posts narrower Q2 loss and trims costs, but shares dip as U.S. revenues and visit volumes decline.
Teladoc ( TDOC ) Q2 Revenue Tops Estimates
Teladoc Health ( NYSE:TDOC ) , a virtual healthcare provider offering telemedicine and digital health services, released its second quarter earnings results on July 29, 2025, covering the period ending June 30. The most notable news from the release was that GAAP revenue reached $631.9 million, ...
Teladoc Health Reports Smaller-Than-Expected Q2 Loss, Revenue Tops Estimates - Teladoc Health ( NYSE:TDOC )
Teladoc reports second-quarter revenue of $631.9 million, beating analyst estimates of $623.1 million. Teladoc reports a second-quarter loss of 19 cents per share, beating analyst estimates for a loss of 25 cents per share. Get special access to three exclusive "Top 10 Stocks" power lists today, ...
HIMS vs. TDOC: Which Direct-to-Consumer Health Stock Wins Now?
Hims & Hers and Teladoc Health are reshaping virtual care, but which has the edge in earnings growth and strategic expansion? Let's see.
This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Applied Optoelectronics ( NASDAQ:AAOI ) , Arcutis Biotherapeutics ( NASDAQ:ARQT )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Needham analyst Ryan Koontz initiated coverage on Applied Optoelectronics, Inc.
Healthy Returns: Researchers move closer to a universal cancer vaccine
University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings season is approaching.
The Zacks Analyst Blog Highlights Hims & Hers Health, Teladoc Health and American Well
HIMS accelerates global growth with ZAVA buyout, Canadian launch, and soaring EPS estimates pointing to 177.8% upside.
Hims & Hers Paves the Way for Global Digital Health Expansion
HIMS accelerates its global push with the ZAVA acquisition and a planned Canada launch targeting affordable obesity care.
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition?
OptimizeRx bets on EHR-linked messaging and geo-targeting to stand out, but scaling in a crowded digital health field remains key.
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally?
HIMS benefits from strong online revenue, subscriber growth, and global expansion moves to fuel its health platform momentum. However, challenges may hurt performance.
Teladoc Health to Announce Second Quarter 2025 Financial Results - Teladoc Health ( NYSE:TDOC )
NEW YORK, July 16, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health Inc. TDOC, the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at ...
Teladoc Health to Announce Second Quarter 2025 Financial Results
NEW YORK, July 16, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health Inc. ( NYSE: TDOC ) , the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market closes. In conjunction, the company will host a conference call to review ...
Teladoc Health Launches Wellbound Employee Assistance Program ( EAP ) - Teladoc Health ( NYSE:TDOC )
NEW YORK, July 15, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health TDOC, the global leader in virtual care, today announced the launch of Wellbound, a bold new employee assistance program ( EAP ) designed to empower a more engaged, healthier workforce.
Teladoc Health Launches Wellbound Employee Assistance Program ( EAP )
New EAP supports mental health and well-being across a broad spectrum of needs-from everyday work-life challenges to complex mental health conditions.
Hims & Hers Enhances Healthcare Through AI-Driven Personalization
HIMS taps AI and $870 million in funding to deliver smarter, more personalized healthcare through tech-driven innovation.
Teladoc Health Stock Jumps After Citron Research Calls It A 'Coiled Spring' - Teladoc Health ( NYSE:TDOC )
Citron Research believes Teladoc stock is a "coiled spring" at its current valuation. "This isn't incremental - it's transformational," Citron says of the company's recent UpLift acquisition. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy right here.
Hims & Hers Stock Jumps 85.1% in 3 Months: Is It a Buy Now?
HIMS accelerates global growth with ZAVA deal, AI investments and expanded access to obesity care treatments. However, macro challenges may hurt performance.
HIMS' Buyouts Fuel International Expansion & Digital Health Innovation
Hims & Hers accelerates European growth with new ZAVA acquisition, adding localized care and lab testing innovation.
Doximity Declines 4.4% in a Month: How to Play the Stock Now?
DOCS slips 4.4% in a month despite strong Q4 results, margin gains and raised guidance -- is there a buying opportunity?
Teladoc Health to Participate in Upcoming Investor Conference
NEW YORK, June 05, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health, Inc. ( NYSE: TDOC ) , the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare ...
Teladoc Health to Participate in Upcoming Investor Conference - Teladoc Health ( NYSE:TDOC )
NEW YORK, June 05, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health, Inc. TDOC, the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami ...
Teladoc Health to Participate in Upcoming Investor Conference
NEW YORK, June 05, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health, Inc. ( NYSE: TDOC ) , the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare ...
Doximity Rides on Telehealth Demand: Will This Drive Sales Further?
DOCS posts strong Q4 revenue growth and record user engagement as demand for telehealth and AI tools hits new highs.
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
NEW YORK, June 03, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health, Inc. ( NYSE:TDOC ) , the global leader in virtual care, today announced that it issued inducement awards to two new employees.
Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
The FDA approved Novavax's Covid-19 vaccine but with unusual restrictions.
Teladoc's Outlook Clouds As JPMorgan Points To Uncertainty In Behavioral Health, Margin Pressure - Teladoc Health ( NYSE:TDOC )
Teladoc beats Q1 revenue estimates but misses on earnings; lowers full-year outlook and 2025 loss guidance. JP Morgan trims Teladoc price target to $9 as analyst sees weaker growth and lower profit expectations through 2026.
Hims & Hers Stock Declines 3.1% in 3 Months: Is it a Buy Now?
HIMS is expanding its health and wellness products and services and increasing its focus on AI to solidify its footing. However, macro challenges may hurt performance.
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid
Equity markets are full of bargains -- stocks that have performed terribly in recent months, whether due to trade-related marketwide issues or company-specific troubles, but could bounce back once things improve. There are also companies that are not performing well and are unlikely to rebound ...
What Lessons Can Investors Learn From Cathie Wood's Ark Invest's Aggressive Investment Philosophy?
Cathie Wood has become best known for a relatively aggressive investment philosophy. She and her team at Ark Invest target companies promoting cutting-edge technologies, which bring with them high risks but the potential for considerable rewards.This differs from investors like Warren Buffett, ...
TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit
Teladoc Health expects Integrated Care members to be between 101 million and 103 million in 2025.
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
PURCHASE, N.Y., May 02, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health, Inc. ( NYSE:TDOC ) , the global leader in virtual care, today announced that it issued inducement awards to five new employees.
Teladoc Health Stock Slides On Q1 Earnings As Company Cuts FY25 Guidance - Teladoc Health ( NYSE:TDOC )
Teladoc reports first-quarter revenue of $629.4 million, beating the consensus estimate of $619.29 million. Teladoc reports a first-quarter loss of 53 cents per share, missing analyst estimates for a loss of 34 cents per share. Don't face extreme market conditions unprepared.
Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental Health Care Services Through Covered Benefits - Teladoc Health ( NYSE:TDOC )
PURCHASE, NY, April 30, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health TDOC, the global leader in virtual care, today announced it has acquired UpLift, an innovative and tech-enabled provider of virtual mental health therapy, psychiatry and medication management services.
Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?
Both HIMS and TDOC are technology-intensive healthcare companies that leverage their strengths in the digital health space to enhance their platforms. Which one is a better investment? Let's see.
Unveiling Teladoc ( TDOC ) Q1 Outlook: Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Teladoc (TDOC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Teladoc Health to Announce First Quarter 2025 Financial Results - Teladoc Health ( NYSE:TDOC )
PURCHASE, NY, April 16, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health Inc. TDOC, the global leader in virtual care, announced that it will release first quarter 2025 results on Wednesday, April 30, 2025, after the market closes. In conjunction, the company will host a conference call to review ...
Teladoc Health to Announce First Quarter 2025 Financial Results
PURCHASE, NY, April 16, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health Inc. ( NYSE: TDOC ) , the global leader in virtual care, announced that it will release first quarter 2025 results on Wednesday, April 30, 2025, after the market closes. In conjunction, the company will host a conference call to ...
Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it
HIMS is enhancing offerings and expanding its health and wellness products and services to solidify its footing. However, macro challenges are likely to hurt its performance.
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. It's a great strategy, but it's essential to avoid those companies that only look undervalued but actually aren't.Some stocks are lagging the ...
Teladoc Health Introduces Next Generation Cardiometabolic Health Program - Teladoc Health ( NYSE:TDOC )
PURCHASE, NY, April 08, 2025 ( GLOBE NEWSWIRE ) -- Teladoc Health TDOC, the global leader in virtual care, today introduced its next generation Cardiometabolic Health Program to improve population health and prevent the progression of diabetes, hypertension and obesity.
Should Investors Buy These 2 Beaten-Down Artificial Intelligence ( AI ) Healthcare Stocks?
Artificial intelligence ( AI ) is changing the world. Corporations are racing to establish themselves as leaders in the field, while investors want to cash in by putting their hard-earned money into the most promising AI companies.
Newsweek and Statista Reveal the 2025 Most Trustworthy Companies in America
Fourth annual ranking recognizes 700 companies across 23 industries for their commitment to trust among customers, employees, and investors NEW YORK, March 26, 2025 ( GLOBE NEWSWIRE ) -- Newsweek, in partnership with market research firm Statista, has unveiled its fourth annual ranking of the ...
Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy?
Telemedicine specialist Teladoc Health ( NYSE: TDOC ) has been a terrible investment over the past three years. Once the company's pandemic-fueled business boom cooled down, its revenue and visit growth slowed down considerably while it remained unprofitable.However, Teladoc is trying to turn ...
